Shares of Organon & Co (NYSE:OGN) rose sharply in pre-market trading as the company agreed to be acquired by Sun Pharma in an $11.75 billion deal.

Sun Pharma will acquire all outstanding shares of Organon for $14.00 per share.

Organon shares jumped 14.8% to $12.93 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Onconetix Inc (NASDAQ:ONCO) gained 46.4% to $0.86 in pre-market trading after the company announced the resignation of Andrew Oakley as chairman of board.
• DarkIris Inc (NASDAQ:DKI) gained 34.1% to $0.62 in pre-market trading. The company announced closing of a $3.8 million PIPE financing and $800,000 content asset acquisition.
• Aditxt Inc (NASDAQ:ADTX) rose 30.8% to $0.37 in pre-market trading after falling over 2% on Friday.
• Intellia Therapeutics Inc (NASDAQ:NTLA) rose 25.6% to $17.12 in pre-market trading after the company announced it will report topline clinical data from its global Phase 3 HAELO trial of lonvoguran ziclumeran in hereditary angioedema on April 27.
• SMX (Security Matters) PLC (NASDAQ:SMX) gained 17.9% to $2.45 in pre-market trading after dipping over 40% on Friday.
• Atomera Inc (NASDAQ:ATOM) rose 15.3% to $9.92 in pre-market trading. Atomera shares jumped 39% on Friday after the company announced an expanded collaboration with Synopsys to advance gallium nitride device modeling for radio frequency and power semiconductor applications.
• Maison Solutions Inc (NASDAQ:MSS) gained 14.5% to $1.34 in pre-market trading after rising 4% on Friday.
• POET Technologies Inc (NASDAQ:POET) jumped 10.7% to $16.72 in pre-market trading after surging more than 28% on Friday.
• Compass Therapeutics Inc. (NASDAQ:CMPX) gained 10.5% to $5.55 in pre-market trading. Compass Therapeutics will host webcast on April 27 to review topline secondary endpoints from Phase 2/3 COMPANION-002 clinical study assessing tovecimig in combination with paclitaxel in advanced biliary tract cancer.

Losers

• Chanson International Holding (NASDAQ:CHSN) fell 29.4% to $0.13 in pre-market trading after dipping more than 92% on Friday.
• Cheetah Net Supply Chain Service Inc (NASDAQ:CTNT) declined 22.5% to $0.033 in pre-market trading after the company disclosed a 1-for-200 reverse stock split.
• Nuvve Holding Corp (NASDAQ:NVVE) tumbled 20.1% to $0.40 in pre-market trading after gaining 3% on Friday.
• Q32 Bio Inc (NASDAQ:QTTB) shares dipped 19.6% to $5.00 in pre-market trading. Q32 Bio filed prospectus to launch a new $75 million at-the-market offering program.
• Scinai Immunotherapeutics Ltd – ADR (NASDAQ:SCNI) fell 13.8% to $0.64 in pre-market trading. Scinai Immunotherapeutics shares jumped 62% on Friday after the company announced a $2.61 million private placement financing.
• Medicus Pharma Ltd (NASDAQ:MDCX) fell 13.3% to $0.27 in pre-market trading after declining 5% on Friday.
• Fitell Corp (NASDAQ:GMEX) dipped 12.1% to $0.41 in pre-market trading after gaining 25% on Friday.
• Nuburu Inc (NYSE:BURU) fell 11.2% to $0.28 in pre-market trading. Nuburu filed prospectus for resale of up to 60 million shares of common stock by YA II PN, LTD.
• Orion Group Holdings Inc (NYSE:ORN) fell 7.9% to $11.30 in pre-market trading.
• MMTec Inc (NASDAQ:MTC) dipped 6.7% to $6.26 in pre-market trading after gaining 3% on Friday.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.